Roche launches Vabysmo® (faricimab), the first and only bispecific monoclonal antibody for the eye, to treat two leading causes of vision loss
Mumbai, March 07, 2024: Roche Pharma India marked its foray into the Ophthalmology space by launching Vabysmo® (faricimab) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and…